B A Mulley

710 total citations
31 papers, 533 citations indexed

About

B A Mulley is a scholar working on Organic Chemistry, Environmental Chemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, B A Mulley has authored 31 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 6 papers in Environmental Chemistry and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in B A Mulley's work include Surfactants and Colloidal Systems (9 papers), Analytical Methods in Pharmaceuticals (5 papers) and Analytical Chemistry and Chromatography (4 papers). B A Mulley is often cited by papers focused on Surfactants and Colloidal Systems (9 papers), Analytical Methods in Pharmaceuticals (5 papers) and Analytical Chemistry and Chromatography (4 papers). B A Mulley collaborates with scholars based in United Kingdom, United States and Sudan. B A Mulley's co-authors include Henry Chrystyn, M. Peake, J E Carless, G D Parr, A H Beckett, Peter Shaw, N. C. SIDDLE, K. Miloszewski, J. Mould and Kyosuke Takeshita and has published in prestigious journals such as Journal of Pharmaceutical Sciences, British Journal of Anaesthesia and Alimentary Pharmacology & Therapeutics.

In The Last Decade

B A Mulley

31 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B A Mulley United Kingdom 12 244 117 83 78 76 31 533
V. Bansal United States 12 180 0.7× 86 0.7× 33 0.4× 49 0.6× 52 0.7× 21 565
H.B. Kostenbauder United States 21 310 1.3× 92 0.8× 267 3.2× 57 0.7× 67 0.9× 78 1.2k
Richard E. Powell United States 16 182 0.7× 220 1.9× 36 0.4× 129 1.7× 109 1.4× 33 1.0k
E. Rillaerts Belgium 12 192 0.8× 48 0.4× 21 0.3× 46 0.6× 82 1.1× 24 559
Yuriko Kato Japan 15 119 0.5× 25 0.2× 91 1.1× 51 0.7× 70 0.9× 66 806
John K. Clark United Kingdom 16 247 1.0× 152 1.3× 132 1.6× 68 0.9× 101 1.3× 33 1.4k
Hisashi Nogami Japan 13 132 0.5× 29 0.2× 185 2.2× 11 0.1× 189 2.5× 99 843
A. H. Beckett United Kingdom 18 175 0.7× 16 0.1× 168 2.0× 69 0.9× 20 0.3× 51 1.0k
Karl Jacob Germany 15 107 0.4× 55 0.5× 249 3.0× 28 0.4× 126 1.7× 40 896
David Bush United States 18 285 1.2× 13 0.1× 208 2.5× 18 0.2× 204 2.7× 30 1.2k

Countries citing papers authored by B A Mulley

Since Specialization
Citations

This map shows the geographic impact of B A Mulley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B A Mulley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B A Mulley more than expected).

Fields of papers citing papers by B A Mulley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B A Mulley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B A Mulley. The network helps show where B A Mulley may publish in the future.

Co-authorship network of co-authors of B A Mulley

This figure shows the co-authorship network connecting the top 25 collaborators of B A Mulley. A scholar is included among the top collaborators of B A Mulley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B A Mulley. B A Mulley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peake, M., Henry Chrystyn, & B A Mulley. (1989). Response to oral theophylline in severe chronic obstructive airways disease: Authors' reply. BMJ. 298(6672). 523.3–524. 4 indexed citations
2.
Chrystyn, Henry, et al.. (1989). Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.. British Journal of Clinical Pharmacology. 27(2). 215–221. 11 indexed citations
3.
Chrystyn, Henry, B A Mulley, & M. Peake. (1988). Dose response relation to oral theophylline in severe chronic obstructive airways disease.. BMJ. 297(6662). 1506–1510. 114 indexed citations
4.
Mulley, B A, et al.. (1988). Effect of Dispersion on the Coloring Properties of Aluminum Dye Lakes. Journal of Pharmaceutical Sciences. 77(10). 866–871. 4 indexed citations
5.
Chrystyn, Henry, et al.. (1988). The Accuracy and Stability of Bayesian Theophylline Predictions. Therapeutic Drug Monitoring. 10(3). 299–305. 14 indexed citations
6.
Mulley, B A, et al.. (1987). Comparison of the effectiveness of midazolam and diazepam in lipid emulsion as sedation during upper gastrointestinal endoscopy. Alimentary Pharmacology & Therapeutics. 1(5). 409–414. 12 indexed citations
7.
Chrystyn, Henry, et al.. (1987). The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.. British Journal of Clinical Pharmacology. 24(3). 301–307. 11 indexed citations
8.
Mulley, B A, et al.. (1984). Microstructure of Aluminum Hydroxides and the Formation of Aluminum Dye Lakes. Journal of Pharmaceutical Sciences. 73(12). 1738–1744. 8 indexed citations
9.
Hargreaves, David, et al.. (1983). PLASMA XANTHINE LEVELS IN PREMATURE INFANTS TREATED FOR APNOEA WITH THEOPHYLLINE. Journal of Clinical Pharmacy and Therapeutics. 8(2). 133–136. 1 indexed citations
10.
Mulley, B A, et al.. (1982). Plasma Concentrations and Clinical Effects of Lorazepam after Oral Administration. Survey of Anesthesiology. 26(2). 70–70. 1 indexed citations
11.
Mulley, B A, et al.. (1978). INTERACTIONS BETWEEN DIAZEPAM AND PARACETAMOL. Journal of Clinical Pharmacy and Therapeutics. 3(1). 25–35. 3 indexed citations
12.
Mulley, B A, et al.. (1977). PHARMACOKINETIC MANAGEMENT OF STREPTOMYCIN DOSAGE. Journal of Clinical Pharmacy and Therapeutics. 2(3). 155–161. 2 indexed citations
13.
Mulley, B A, et al.. (1972). Effect of micelle formation and the nature of the oil-phase on the distribution of a non-ionic surfactant in three- and four-component emulsions. Journal of Pharmacy and Pharmacology. 24(9). 729–734. 7 indexed citations
14.
Mulley, B A, et al.. (1971). Further evidence on the question of polymorphism in aspirin. Journal of Pharmacy and Pharmacology. 23(11). 902–904. 13 indexed citations
15.
Mulley, B A, et al.. (1970). Multiple-drop formation in emulsions. Journal of Pharmacy and Pharmacology. 22(3). 243–245. 8 indexed citations
16.
Mulley, B A, et al.. (1964). Nonionic surface-active agents. Part VI. Phase equilibria in binary and ternary systems containing nonionic surface-active agents. Journal of Colloid Science. 19(6). 501–515. 31 indexed citations
18.
Mulley, B A, et al.. (1956). Non-ionic surface-active agents. I. The solubility of chloroxylenol in aqueous solutions of polyethylene glycol 1000 monocetyl ether.. PubMed. 8(10). 774–80. 2 indexed citations
19.
Mulley, B A, et al.. (1956). Non-Ionic Surface-Active Agents. Journal of Pharmacy and Pharmacology. 8(1). 774–780. 43 indexed citations
20.
Beckett, A H & B A Mulley. (1955). Steric interactions in substituted cyclohexadienes. Part I. meso-substituted dihydroanthracenes : steric effects in the reactions of cis- and trans-isomers. Journal of the Chemical Society (Resumed). 4159–4159. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026